FILLMED (FILORGA) NCTF 135®

Filorga NCTF 135 is a hyaluronic acid-based solution, and is intended for use in biological rejuvenation, revitalising mesotherapy, and the hydration of tired, old skin. It also works for flattening and smoothing out superficial wrinkles.

Manufactured by Laboratoires Filorga, this formula contains 55 unique active ingredients, each of which is used to treat photodamaged skin and reverse the signs of ageing. It actively repairs the skin, while also reducing deficiencies in minerals, including calcium, sodium, potassium, and magnesium.

Filorga NCTF 135 contains a hyaluronic acid concentration of 0.025mg/mL. Each package comes with 5 prefilled 3ml syringes, 5-18G withdrawal needles, 5-30G therapy needles, and 5-32G therapy needles. This fragile dermal filler should be stored between 2 and 25°C.

Filorga NCTF 135 was specifically formulated to enhance the hydration and flexibility of the skin, offering it a more radiant and healthy appearance. Its hyaluronic acid content replenishes lost endogenous hyaluronic acid, which redensifies the dermis, adds hydration to the skin, and promotes collagen regeneration.

This dermal filler may be used as a form of mesotherapy, working to treat the first signs of visible ageing in patients. These may include wrinkles and fine lines, elasticity loss, sagging, dullness, dehydration, and skin depressions.

This dermal filler leaves skin with a healthy glow, while smoothing out any rough texture and fine lines. Filorga NCTF 135 is intended for use on the face, neck, decolletage, inside of the wrists, inner thighs, and abdomen.

After a single injection, Filorga NCTF 135’s hyaluronic acid content helps the skin to retain moisture, leaving it with a healthy and refreshed appearance. Over time, the formula’s other active ingredients work to stimulate the production of new skin cells, helping to improve the patient’s overall skin quality.

The vitamins present in this facial filler work to stimulate cell functions, while its nucleic acid bases improve the communication between cells. Moreover, its coenzymes catalyse biochemical reactions, the amino acids stimulate protein production, and minerals prevent and repair skin deficiencies. Finally, its active antioxidants prevent free radicals from further damaging the skin. Together, these ingredients improve the appearance of the skin while also boosting its health over time.

Only licensed, properly trained medical practitioners should perform treatments with Filorga NCTF 135. The treatment should be performed with an injector gun, or with the needles provided in the package.

This cosmetic filler may be injected into a variety of problem areas via the superficial dermis or the dermal-epidermal connective tissues. It is suitable for use in the abdomen and limbs, as well as the facial area, neck, and decolletage.

Please inform the patient that it will take a minimum of 5 treatment sessions, spaced over the course of 3 months, for them to see significant improvement.

Initial injections with Filorga NCTF 135 are to be performed over the course of 3 months, with maintenance sessions occurring every 3 months after this period.

When beginning treatment with this filler, the patient should be given 3 Filorga NCTF 135 injections with an interval of 15 days between each session. After this, the patient should receive 2 treatments spaced out by a month, followed by renewal sessions every 3 months.

However, due to the unique nature of each patient’s skin, the physician should determine suitable intervals for treatment in each individual case. Please note that the revitalisation of mature skin will require more recurrent treatments than that of younger skin.

Filorga NCTF 135 is a perfectly safe injectable solution for patient use, backed by 10 years of success and the treatment of more than a million patients. That being said, certain individuals should not be injected with this filler, including those who are sensitive to hyaluronic acid.

For a full list of the product contraindications, see the package insert.

While most patients react well to treatments with Filorga NCTF 135, some individuals may experience side effects following injection. However, these common reactions are usually mild in nature, and should resolve themselves within a week of initial treatment.

• Swelling
• Redness
• Bruising
• Itching
• Nodules
• Discolouration

• Necrosis
• Abscess
• Granuloma
• Hypersensitivity

Filorga NCTF 135 a hyaluronic acid-based filler, allowing it to add volume and hydration to the skin through its unique water retaining properties. With this, it plumps up ageing, creased skin, working to smooth out its wrinkles and fine lines. Additionally, the hyaluronic acid in this filler works to stimulate the production of elastin and collagen, improving the skin’s overall texture and appearance.

In addition to hyaluronic acid, Filorga NCTF 135 contains 55 active ingredients.

• 24 amino acids, which increase collagen and elastin production;
• 14 vitamins (like vitamin A, B, C and E), which encourage the skin cells’ vital functions;
• 6 coenzymes, which act as catalysts in the skin tissue’s bio-chemical reactions;
• 5 nucleic acid bases, which encourage cellular communication;
• 4 minerals, which correct deficiencies in the skin;
• And 2 antioxidants, which protect the skin against free radical damage.

When combined, these powerful ingredients provide the skin with all of the nutrients necessary for its processes of reparation and protection.

Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.